| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Christian R Lee, James M Teppe. Basal ganglia control of substantia nigra dopaminergic neurons. Journal of neural transmission. Supplementum. issue 73. 2010-05-14. PMID:20411769. |
however, afferents to these neurons, a large proportion of them gabaergic and arising from other nuclei in the basal ganglia, play a crucial role in modulating the activity of dopaminergic neurons. |
2010-05-14 |
2023-08-12 |
Not clear |
| Ezia Guatteo, Maria Letizia Cucchiaroni, Nicola B Mercur. Substantia nigra control of basal ganglia nuclei. Journal of neural transmission. Supplementum. issue 73. 2010-05-14. PMID:20411770. |
here we overview the electrophysiological properties of these substantia nigra neurons in the pars compacta and reticulata, together with their synaptic connections, and discuss the functional effects of dopaminergic and gabaergic inputs within the basal ganglia. |
2010-05-14 |
2023-08-12 |
Not clear |
| Cindy Casteels, Erwin Lauwers, Abdelbari Baitar, Guy Bormans, Veerle Baekelandt, Koen Van Laer. In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease. Brain research. vol 1316. 2010-05-06. PMID:20026090. |
type 1 cannabinoid (cb1) receptors are expressed in high concentrations in the central nervous system, including the basal ganglia, and could have direct or indirect effects on motor behavior through modulation of dopaminergic, glutamatergic and gaba-ergic neurotransmission. |
2010-05-06 |
2023-08-12 |
rat |
| George H Sac. Mitochondrial matters in Parkinson disease: introduction. Journal of bioenergetics and biomembranes. vol 41. issue 6. 2010-04-21. PMID:20039109. |
the central nervous system changes involve dopaminergic neurons in the basal ganglia and substantia nigra. |
2010-04-21 |
2023-08-12 |
Not clear |
| Mati Joshua, Avital Adler, Hagai Bergma. The dynamics of dopamine in control of motor behavior. Current opinion in neurobiology. vol 19. issue 6. 2010-04-16. PMID:19896833. |
here, we suggest that the temporal dynamics of the response of dopaminergic neurons (dans) enable the basal ganglia to have a dual role. |
2010-04-16 |
2023-08-12 |
Not clear |
| Gabriella Santangelo, Carmine Vitale, Luigi Trojano, Danilo De Gaspari, Leonilda Bilo, Angelo Antonini, Paolo Baron. Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions. Movement disorders : official journal of the Movement Disorder Society. vol 25. issue 1. 2010-04-06. PMID:20014112. |
regardless of the presence of dopaminergic denervation, cerebrovascular lesions in hemispheric white matter, basal ganglia, and cerebellum have an important effect in determining early onset and severity of cognitive impairment in patients with parkinsonism. |
2010-04-06 |
2023-08-12 |
Not clear |
| Fabrizio Stocch. The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson's disease. Parkinsonism & related disorders. vol 15 Suppl 3. 2010-03-31. PMID:20083012. |
this hypothesis has arisen from studies of the normal basal ganglia demonstrating that nigral dopaminergic neurons normally fire continuously and striatal dopamine levels are relatively constant. |
2010-03-31 |
2023-08-12 |
monkey |
| Christian Beste, Carsten Saft, Jürgen Andrich, Ralf Gold, Michael Falkenstei. Error processing in Huntington's disease. PloS one. vol 1. 2010-03-16. PMID:17183717. |
huntington's disease (hd) is a genetic disorder expressed by a degeneration of the basal ganglia inter alia accompanied with dopaminergic alterations. |
2010-03-16 |
2023-08-12 |
Not clear |
| Hélène N Davi. Towards a reconceptualization of striatal interactions between glutamatergic and dopaminergic neurotransmission and their contribution to the production of movements. Current neuropharmacology. vol 7. issue 2. 2010-03-05. PMID:19949572. |
according to the current model of the basal ganglia organization, simultaneous activation of the striato-nigral direct pathway by glutamatergic and dopaminergic neurotransmission should lead to a synergistic facilitatory action on locomotor activity, while in contrast activation of the indirect pathway by these two neurotransmittions should lead to antagonistic effects on locomotor activity. |
2010-03-05 |
2023-08-12 |
Not clear |
| I A Iselin-Chaves, H Grötzsch, M Besson, P R Burkhard, G L Savoldell. Naloxone-responsive acute dystonia and parkinsonism following general anaesthesia. Anaesthesia. vol 64. issue 12. 2010-02-18. PMID:19839983. |
the postulated mechanism involves an imbalance between dopaminergic and cholinergic neurotransmitters in the basal ganglia. |
2010-02-18 |
2023-08-12 |
Not clear |
| Samuel D Gale, David J Perke. A basal ganglia pathway drives selective auditory responses in songbird dopaminergic neurons via disinhibition. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 30. issue 3. 2010-02-05. PMID:20089911. |
a basal ganglia pathway drives selective auditory responses in songbird dopaminergic neurons via disinhibition. |
2010-02-05 |
2023-08-12 |
Not clear |
| Samuel D Gale, David J Perke. A basal ganglia pathway drives selective auditory responses in songbird dopaminergic neurons via disinhibition. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 30. issue 3. 2010-02-05. PMID:20089911. |
here, we demonstrate activation of dopaminergic neurons in songbirds driven by a basal ganglia region required for vocal learning, area x. dopaminergic neurons in anesthetized zebra finches respond more strongly to the bird's own song (bos) than to other sounds, and area x is critical for these responses. |
2010-02-05 |
2023-08-12 |
Not clear |
| Samuel D Gale, David J Perke. A basal ganglia pathway drives selective auditory responses in songbird dopaminergic neurons via disinhibition. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 30. issue 3. 2010-02-05. PMID:20089911. |
thus, dopaminergic neurons can be disinhibited selectively by complex sensory stimuli via input from the basal ganglia. |
2010-02-05 |
2023-08-12 |
Not clear |
| Abdoul Kane, William D Hutchison, Mojgan Hodaie, Andres M Lozano, Jonathan O Dostrovsk. Dopamine-dependent high-frequency oscillatory activity in thalamus and subthalamic nucleus of patients with Parkinson's disease. Neuroreport. vol 20. issue 17. 2010-02-02. PMID:19829159. |
these findings confirm and extend earlier findings suggesting that in pd there are marked changes in basal ganglia oscillatory activity and that these can be reversed after dopaminergic therapy. |
2010-02-02 |
2023-08-12 |
Not clear |
| Jun Jia, ZuoLi Sun, Bo Li, YanLi Pan, HaoMin Wang, Xuan Wang, Fen Yu, LiMin Liu, LiJuan Zhang, XiaoMin Wan. Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats. Behavioural brain research. vol 205. issue 1. 2010-01-12. PMID:19549545. |
these results suggest that the effects of high frequency ea on motor symptoms of parkinsonian rats may involve restoration of the homeostasis of dopaminergic transmission in the basal ganglia circuit. |
2010-01-12 |
2023-08-12 |
rat |
| S Arpin, E Lagrue, S Bodard, S Chalon, P Castelna. Basal ganglia neuroprotection with anticonvulsants after energy stress: a comparative study. Metabolic brain disease. vol 24. issue 3. 2009-12-30. PMID:19789969. |
the membrane dopamine transporter (dat) density, which provides a reliable index of dopaminergic neurons survival in the basal ganglia, was assessed by semi-quantitative autoradiography of the striatum. |
2009-12-30 |
2023-08-12 |
mouse |
| Judy Zhu, Wenjing Xu, Jing Wang, Syed F Ali, Jesus A Angul. The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice. Journal of neurochemistry. vol 111. issue 3. 2009-11-06. PMID:19682209. |
our findings are relevant for the treatment of meth abuse and may be relevant to certain neurological disorders involving the dopaminergic circuitry of the basal ganglia. |
2009-11-06 |
2023-08-12 |
mouse |
| Kaoru Takakusak. [Motor control by the basal ganglia]. Rinsho shinkeigaku = Clinical neurology. vol 49. issue 6. 2009-10-22. PMID:19618841. |
we propose that basal ganglia disfunction, including the abnormality in the dopaminergic projection system, may disturb the cooperative regulation, resulting in motor deficiencies expressed in basal diseases. |
2009-10-22 |
2023-08-12 |
Not clear |
| Emanuela Santini, Myriam Heiman, Paul Greengard, Emmanuel Valjent, Gilberto Fison. Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia. Science signaling. vol 2. issue 80. 2009-09-29. PMID:19622833. |
parkinson's disease (pd), a disorder caused by degeneration of the dopaminergic input to the basal ganglia, is commonly treated with l-dopa. |
2009-09-29 |
2023-08-12 |
mouse |
| Anna L Bartels, Klaus L Leender. Parkinson's disease: the syndrome, the pathogenesis and pathophysiology. Cortex; a journal devoted to the study of the nervous system and behavior. vol 45. issue 8. 2009-09-22. PMID:19095226. |
an important pathophysiological feature in pd is the loss of part of the dopaminergic neurons in the substantia nigra (sn) resulting in a specific dysorganisation of the complicated basal ganglia (bg) circuits. |
2009-09-22 |
2023-08-12 |
Not clear |